Nabriva Therapeutics AG ADR buy klostergang
Start price
25.08.17
/
50%
?7.59
Target price
27.08.18
€15.64
Performance (%)
-67.54%
End price
27.08.18
€2.46
Summary
This prediction ended on 27.08.18 with a price of €2.46. The BUY prediction by klostergang for Nabriva Therapeutics AG ADR performed very badly with a performance of -67.54%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nabriva Therapeutics AG ADR | - | - | - | - |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
Comments by klostergang for this prediction
In the thread Nabriva Therapeutics AG ADR diskutieren
klostergang stimmt der Outperform-Einschätzung der institutionellen Analysten zu
klostergang stimmt am 25.08.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 17.34$ zu.
(Laufzeit überschritten)